Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research of Brain White Matter Hyperintensity in Migraine Using a Cerebrovascular Reactivity Mapping Based on BOLD MRI

NCT03494673 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03494673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03494673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research of Brain White Matter Hyperintensity in Migraine Using a Cerebrovascular Reactivity Mapping Based on BOLD MRI
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
July 13, 2018
Completion date
February 28, 2020
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine